0.48
0.48 (0%)
As of Feb 14, 2025
Sensei Biotherapeutics, Inc. [SNSE]
Source:
Company Overview
Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients.
| Country | United States |
| Headquarters | rockville, maryland |
| Phone Number | (240) 243-8000 |
| Industry | manufacturing |
| CEO | John Celebi |
| Website | www.senseibio.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-32.6 |
| Net Income | $-30.2 |
| Net Cash | $-3 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -50.4% |
| Profit as % of Stockholder Equity | -78.6% |
Management Effectiveness
| Return on Equity | -78.6% |
| Return on Assets | -66.5% |
| Turnover Ratio | |
| EBITA | $-32.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $45.4 |
| Total Liabilities | $7 |
| Operating Cash Flow | $-24.7 |
| Investing Cash Flow | $22.4 |
| Financing Cash Flow | $-0.8 |
